Joseph W. Harding

10.6k total citations
186 papers, 8.9k citations indexed

About

Joseph W. Harding is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joseph W. Harding has authored 186 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 80 papers in Cardiology and Cardiovascular Medicine and 76 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joseph W. Harding's work include Renin-Angiotensin System Studies (79 papers), Receptor Mechanisms and Signaling (62 papers) and Neuropeptides and Animal Physiology (44 papers). Joseph W. Harding is often cited by papers focused on Renin-Angiotensin System Studies (79 papers), Receptor Mechanisms and Signaling (62 papers) and Neuropeptides and Animal Physiology (44 papers). Joseph W. Harding collaborates with scholars based in United States, Switzerland and South Africa. Joseph W. Harding's co-authors include John W. Wright, John W. Wright, Luke T. Krebs, J.M. Hanesworth, Christopher J. Davis, Enikö A. Kramár, Michael F. Sardinia, Dominik Felix, Jodie M. Hanesworth and Frank L. Margolis and has published in prestigious journals such as Science, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Joseph W. Harding

184 papers receiving 8.7k citations

Peers

Countries citing papers authored by Joseph W. Harding

Since Specialization

Citations

This map shows the geographic impact of Joseph W. Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph W. Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph W. Harding more than expected).

Fields of papers citing papers by Joseph W. Harding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph W. Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph W. Harding. The network helps show where Joseph W. Harding may publish in the future.

Co-authorship network of co-authors of Joseph W. Harding

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph W. Harding. A scholar is included among the top collaborators of Joseph W. Harding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph W. Harding. Joseph W. Harding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hepatocyte growth factor mimetic confers protection from aminoglycoside-induced hair cell death in vitro 2023 ·Hearing Research ·(unknown), (unknown), (unknown), Meiyan Jiang, Joseph W. Harding, Peter S. Steyger, Allison B. Coffin	3
2	Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis 2022 ·Journal of Antimicrobial Chemotherapy ·(unknown), Maxwell Chirehwa, Elisa H. Ignatius, Richard Court, Xin Sun, Laura Moran, Richard Hafner, Lubbe Wiesner, Susan L. Rosenkranz, Veronique de Jager, (unknown), Joseph W. Harding, Tawanda Gumbo, Susan Swindells, Andreas H. Diacon, Kelly E. Dooley, Helen McIlleron, Paolo Denti	7
3	Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis 2021 ·International Journal of Infectious Diseases ·Richard Court, Chad M. Centner, Maxwell Chirehwa, Lubbe Wiesner, Paolo Denti, (unknown), Joseph W. Harding, Tawanda Gumbo, Gary Maartens, Helen McIlleron	31
4	Effect of Isoniazid Intake on Ethionamide Pharmacokinetics and Target Attainment in Multidrug-Resistant Tuberculosis Patients 2021 ·Antimicrobial Agents and Chemotherapy ·Maxwell Chirehwa, Richard Court, (unknown), Lubbe Wiesner, (unknown), Joseph W. Harding, Tawanda Gumbo, Gary Maartens, Robin M. Warren, Paolo Denti, Helen McIlleron	5
5	Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone 2020 ·Antimicrobial Agents and Chemotherapy ·Maxwell Chirehwa, Richard Court, (unknown), Lubbe Wiesner, (unknown), Joseph W. Harding, Tawanda Gumbo, Gary Maartens, Robin M. Warren, Paolo Denti, Helen McIlleron	19
6	Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis 2018 ·The International Journal of Tuberculosis and Lung Disease ·Richard Court, Lubbe Wiesner, Maxwell Chirehwa, Annemie Stewart, (unknown), Joseph W. Harding, Tawanda Gumbo, Helen McIlleron, Gary Maartens	1
7	Nicotine-induced conditioned place preference in adolescent rats 2011 ·Pharmacology Biochemistry and Behavior ·(unknown), John W. Wright, Joseph W. Harding	23
8	Effects of suprachiasmatic nucleus lesions on habituation of the head-shake response 2008 ·Neuroscience Letters ·(unknown), Eric S. Murphy, Joseph W. Harding, John W. Wright	2
9	Effects of matrix metalloproteinase inhibition on short‐ and long‐term plasticity of schaffer collateral/CA1 synapses 2007 ·Journal of Neurochemistry ·Peter C. Meighan, Starla E. Meighan, Christopher J. Davis, John W. Wright, Joseph W. Harding	83
10	Norleucine1-Angiotensin IV alleviates mecamylamine-induced spatial memory deficits 2004 ·Peptides ·Mikel L. Olson, (unknown), (unknown), (unknown), Joseph W. Harding, John W. Wright	43
11	Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system 2002 ·Peptides ·John W. Wright, Enikö A. Kramár, Starla E. Meighan, Joseph W. Harding	66
12	A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits 2001 ·Regulatory Peptides ·(unknown), (unknown), Joseph W. Harding, John W. Wright	68
13	The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro 2001 ·Brain Research ·Enikö A. Kramár, Deborah L. Armstrong, Saiko Ikeda, M.J. Wayner, Joseph W. Harding, John W. Wright	86
14	Purification of two equine pepsinogens by use of high-performance liquid chromatography 1999 ·American Journal of Veterinary Research ·Ayman I. Sayegh, Neil V. Anderson, Joseph W. Harding, (unknown), Richard M. DeBowes, Robert C. Ritter, Gordon J. Baker, Gerald R. Reeck	1
15	Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist 1996 ·Regulatory Peptides ·Luke T. Krebs, (unknown), Jodie M. Hanesworth, Michael F. Sardinia, (unknown), John W. Wright, Joseph W. Harding	70
16	AT4 receptor structure-binding relationship: angiotensin IV analogues 1994 ·Peptides ·Michael F. Sardinia, J.M. Hanesworth, (unknown), Joseph W. Harding	61
17	Motion-induced aversions during and after recovery from olfactory nerve section in mice 1993 ·Physiology & Behavior ·(unknown), John W. Wright, Joseph W. Harding	4
18	Brain angiotensin: Critical role in the ongoing regulation of body fluid homeostasis and cardiovascular function 1989 ·Peptides ·Joseph W. Harding, (unknown), Wayne S. Quirk, (unknown), John W. Wright	15
19	Differential effects of aminopeptides inhibitors on angiotensin-induced pressor responses 1988 ·Brain Research ·Margaret J. Sullivan, Joseph W. Harding, John W. Wright	32
20	Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats. 1986 ·PubMed ·John W. Wright, Margaret J. Sullivan, Wayne S. Quirk, (unknown), Joseph W. Harding	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact